DHR
NYSEDANAHER CORP /DE/
Health Care, Life Sciences Tools & Services
$204.76
close 7 Aug 2026
+2.50%
52-week change
$143.93B
market cap
$160.93
$242.80
52-week range
| Line item | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income | ||||||||||||||||||||
| Revenue | $25.11B | $24.57B | $23.88B | $23.89B | $26.64B | $24.80B | $22.28B | $17.91B | $17.05B | $15.52B | $16.88B | $14.43B | $12.87B | $18.28B | $18.26B | $16.09B | $12.55B | $10.52B | $12.26B | $11.03B |
| Cost of revenue | $10.42B | $10.05B | $9.67B | $9.86B | $10.46B | $9.56B | $9.81B | $7.93B | $7.54B | $6.95B | $7.55B | $6.66B | $6.02B | $8.94B | $8.85B | $7.91B | $6.15B | $5.45B | $6.48B | $5.99B |
| Gross profit | $14.69B | $14.52B | $14.21B | $14.03B | $16.19B | $15.24B | $12.48B | $9.98B | $9.51B | $8.57B | $9.33B | $7.77B | $6.85B | $9.34B | $9.41B | $8.18B | $6.40B | $5.07B | $5.79B | — |
| R&D | $1.62B | $1.60B | $1.58B | $1.50B | $1.53B | $1.50B | $1.35B | $1.13B | $1.06B | $956.40M | $975.10M | $861.40M | $769.40M | $1.10B | $1.14B | $1.02B | $774.00M | $600.27M | $696.03M | $601.42M |
| SG&A | $7.95B | $8.24B | $7.76B | $7.33B | $7.12B | $6.82B | $6.90B | $5.59B | $5.39B | $5.04B | $5.62B | $4.75B | $4.04B | $5.12B | $5.18B | $4.61B | $3.60B | $3.12B | $3.30B | $2.71B |
| Operating income | $5.13B | $4.69B | $4.86B | $5.20B | $7.54B | $6.38B | $4.23B | $3.27B | $3.06B | $2.57B | $2.74B | $2.16B | $2.05B | $3.12B | $3.17B | $2.62B | $2.05B | $1.44B | $1.79B | $1.74B |
| Interest expense | $292.00M | $265.00M | $278.00M | $286.00M | $204.00M | $231.00M | $275.00M | $108.00M | $137.00M | $140.10M | $184.40M | $139.80M | $94.70M | $141.20M | $157.50M | $141.60M | $117.10M | $118.65M | $126.47M | $109.70M |
| Tax expense | $772.00M | $633.00M | $747.00M | $823.00M | $818.00M | $1.06B | $849.00M | $873.00M | $556.00M | $371.00M | $457.90M | $292.70M | $447.50M | $825.70M | $711.50M | $512.50M | $511.40M | $239.02M | $404.50M | $423.10M |
| Net income | $4.00B | $3.61B | $3.90B | $4.76B | $7.21B | $6.43B | $3.65B | $3.01B | $2.65B | $2.49B | $2.55B | $3.36B | $2.60B | $2.70B | $2.39B | $2.17B | $1.79B | $1.15B | $1.32B | $1.37B |
| Diluted EPS | $5.64 | $5.05 | $5.29 | $6.38 | $9.66 | $8.61 | $4.89 | $4.05 | $3.74 | $3.53 | $3.65 | $4.74 | $3.63 | $3.80 | $3.36 | $3.11 | $2.64 | $1.73 | $1.98 | $4.19 |
| Gross margin | 58.51% | 59.11% | 59.50% | 58.74% | 60.76% | 61.44% | 55.98% | 55.74% | 55.75% | 55.23% | 55.29% | 53.84% | 53.23% | 51.10% | 51.56% | 50.82% | 51.03% | 48.21% | 47.20% | — |
| Operating margin | 20.42% | 19.09% | 20.37% | 21.77% | 28.29% | 25.71% | 18.99% | 18.25% | 17.92% | 16.58% | 16.20% | 14.98% | 15.89% | 17.07% | 17.33% | 16.27% | 16.33% | 13.69% | 14.58% | 15.79% |
| Net margin | 15.95% | 14.71% | 16.33% | 19.94% | 27.06% | 25.94% | 16.36% | 16.79% | 15.55% | 16.06% | 15.13% | 23.26% | 20.19% | 14.74% | 13.10% | 13.50% | 14.29% | 10.95% | 10.75% | 12.42% |
filed 21 Jul 2026